Company Overview of Sequus Pharmaceuticals, Inc.
Sequus Pharmaceuticals, Inc. manufactures, develops, and distributes pharmaceutical products to treat cancer and infectious diseases. The company develops and markets DOXIL®, an anticancer drug; and AMPHOTEC®, an antifungal drug in the United States. The company was formerly known as Liposome Technology, Inc. and changed its name to Sequus Pharmaceuticals, Inc. in June, 1995. The company was founded in 1981 and is based in Menlo Park, California. As of March 17, 1999, Sequus Pharmaceuticals, Inc. operates as a subsidiary of ALZA Corporation.
960 Hamilton Court
Menlo Park, CA 94025
Founded in 1981
Key Executives for Sequus Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Signase, Inc||United States|
|Monteris Medical US, Inc.||United States|
|mAbVista, Inc.||United States|
|Siva Therapeutics Inc.||United States|
|Pelican Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Sequus Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.